BSE filing, NSE: BORORENEW. Summary written from the filing by ALFA Finder's alert engine.
Borosil Renewables Ltd: key numbers
- Share price
- ₹392.75
- Market cap
- ₹5,781 Cr
- Revenue (annual)
- ₹1,556 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 15.1×Sector 41.7×
- Promoter holding
- 56.02%-2.75% QoQ
- FII holding
- 5.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borosil Renewables Ltd
All →Borosil Renewables Board Meeting Date
Borosil Renewables notified BSE/NSE that its Board meeting is scheduled for 30 October 2026 to approve unaudited Q2/H1 FY27 results. No financial figures or decisions are reported in this advance intimation.
Borosil Renewables Legal & Regulatory
Borosil Renewables received a customs adjudication order imposing total fines and penalties of Rs. 60.30 Lakhs regarding the classification of imported capital goods.
- Value
- ₹0.60 Cr
Borosil Renewables Capacity Expansion: ₹1,100 Cr Investment
Borosil Renewables' board approved revised Rs.1100 Cr cost and March 2027 timeline for its 600 TPD expansion. Delay follows Middle East supply disruptions, funded via internal accruals.
- Value
- ₹1,100 Cr
- Execution
- by end of March 2027
- molten glass production capacity
- 1600 TPD
Borosil Renewables Other Announcement
Borosil Renewables Limited informed the exchange regarding an interview of its Executive Chairman, Mr. Pradeep Kumar Kheruka, with CNBC Bajar concerning the company's general business update.
Borosil Renewables Investor Presentation: Key Takeaways
Borosil Renewables is expanding solar glass capacity to 1,600 TPD to capture a large domestic supply gap, targeting ₹2,500 Cr turnover post-expansion.
- Call
- Guides 60% growth
Borosil Renewables Annual General Meeting
Borosil Renewables Limited conducted its 63rd Annual General Meeting on August 27, 2026. Shareholders considered financial statements, auditor re-appointments, and fund-raising proposals via equity issuance.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.